UMG: UBS reiterates buy rating after CMD

(CercleFinance.com) - UBS reiterates its buy rating on the UMG stock, with a target price of E26, following the presentation of new medium-term targets for 2028 at an investor day (CMD) held in London.


The broker says that UMG has announced encouraging financial targets for 2028, which are higher than current consensus forecasts. We believe that UMG remains a stock to watch.

UBS adds that, as it expected, the investor meeting was not a major catalyst, although forecasts were encouraging and it still believes that the risk/reward ratio is trending upwards.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.